These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 36050585)
21. A perspective on SARS-CoV-2 virus-like particles vaccines. Gao X; Xia Y; Liu X; Xu Y; Lu P; Dong Z; Liu J; Liang G Int Immunopharmacol; 2023 Feb; 115():109650. PubMed ID: 36649673 [TBL] [Abstract][Full Text] [Related]
22. Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms. Jafari A; Danesh Pouya F; Niknam Z; Abdollahpour-Alitappeh M; Rezaei-Tavirani M; Rasmi Y Mol Biol Rep; 2022 Jun; 49(6):4943-4957. PubMed ID: 35235159 [TBL] [Abstract][Full Text] [Related]
23. Potential Drug Strategies to Target Coronaviruses. Sarkar K; Sil PC Adv Exp Med Biol; 2021; 1352():111-124. PubMed ID: 35132597 [TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic. Shao Y; Wu Y; Feng Y; Xu W; Xiong F; Zhang X Front Med; 2022 Apr; 16(2):185-195. PubMed ID: 35226300 [TBL] [Abstract][Full Text] [Related]
25. The find of COVID-19 vaccine: Challenges and opportunities. ElBagoury M; Tolba MM; Nasser HA; Jabbar A; Elagouz AM; Aktham Y; Hutchinson A J Infect Public Health; 2021 Mar; 14(3):389-416. PubMed ID: 33647555 [TBL] [Abstract][Full Text] [Related]
26. Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health Interference. Mukherjee S; Ray SK Infect Disord Drug Targets; 2022; 22(4):e080222200919. PubMed ID: 35135456 [TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus. Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668 [TBL] [Abstract][Full Text] [Related]
28. An Outline of Contributing Vaccine Technologies for SARS CoV2 Advancing in Clinical and Preclinical Phase-Trials. Naz SS; Munir I Recent Pat Biotechnol; 2022; 16(2):122-143. PubMed ID: 35040422 [TBL] [Abstract][Full Text] [Related]
29. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism. Amanpour S Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952 [TBL] [Abstract][Full Text] [Related]
31. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients. Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082 [TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 vaccine candidates in rapid development. Li L; Guo P; Zhang X; Yu Z; Zhang W; Sun H Hum Vaccin Immunother; 2021 Mar; 17(3):644-653. PubMed ID: 33121319 [TBL] [Abstract][Full Text] [Related]
33. Super-rapid race for saving lives by developing COVID-19 vaccines. Uttarilli A; Amalakanti S; Kommoju PR; Sharma S; Goyal P; Manjunath GK; Upadhayay V; Parveen A; Tandon R; Prasad KS; Dakal TC; Ben Shlomo I; Yousef M; Neerathilingam M; Kumar A J Integr Bioinform; 2021 Mar; 18(1):27-43. PubMed ID: 33761582 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast. Inchingolo AD; Malcangi G; Ceci S; Patano A; Corriero A; Vimercati L; Azzollini D; Marinelli G; Coloccia G; Piras F; Barile G; Settanni V; Mancini A; De Leonardis N; Garofoli G; Palmieri G; Isacco CG; Rapone B; Scardapane A; Curatoli L; Quaranta N; Ribezzi M; Massaro M; Jones M; Bordea IR; Tartaglia GM; Scarano A; Lorusso F; Macchia L; Larocca AMV; Aityan SK; Tafuri S; Stefanizzi P; Migliore G; Brienza N; Dipalma G; Favia G; Inchingolo F Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955621 [TBL] [Abstract][Full Text] [Related]
35. COVID-19 vaccine: where are we now and where should we go? Soleimanpour S; Yaghoubi A Expert Rev Vaccines; 2021 Jan; 20(1):23-44. PubMed ID: 33435774 [TBL] [Abstract][Full Text] [Related]
36. From Bench Side to Bed-Travelling on a Road to Get a Safe and Effective Vaccine against COVID-19, Day to Save the Life. Ray SK; Mukherjee S Recent Pat Biotechnol; 2022; 16(1):2-5. PubMed ID: 34886784 [TBL] [Abstract][Full Text] [Related]
37. COVID-19: Prospective Challenges and Potential Vaccines. Shahid Nadeem M; Ali A; Al-Ghamdi MA; Depfenhart M; Azam Khan J; Zamzami MA; Nazia Murtaza B; Kazmi I; Ur Rehman M Altern Ther Health Med; 2020 Aug; 26(S2):72-78. PubMed ID: 32845250 [TBL] [Abstract][Full Text] [Related]
38. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms. Aileni M; Rohela GK; Jogam P; Soujanya S; Zhang B Cells; 2022 Mar; 11(7):. PubMed ID: 35406746 [TBL] [Abstract][Full Text] [Related]
39. [Progress and challenge of vaccine development against 2019-novel coronavirus (2019-nCoV)]. Shi Y; Wang N; Zou QM Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jun; 54(6):614-619. PubMed ID: 32234130 [TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects. Pham MN; Murugesan K; Banaei N; Pinsky BA; Tang M; Hoyte E; Lewis DB; Gernez Y J Allergy Clin Immunol; 2022 Mar; 149(3):907-911.e3. PubMed ID: 34952033 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]